Search Results - "PHARMACOGENOMICS"

Polygenic risk scores in pharmacogenomics: methodological challenges, current applications, and perspectives for clinical implementation.

Authors: Mathey, Carina M. Coenen, Martin Cascorbi, Ingolf et al.

Source: Medizinische Genetik. Jul2026, Vol. 38 Issue 3, p221-229. 9p.

"Should researchers return individual pharmacogenomics results to participants? " A descriptive qualitative study on stakeholder perspectives involved in HIV/AIDS research and treatment in Uganda.

Authors: Nabukenya, Sylvia Kyaddondo, David Twimukye, Adelline et al.

Source: Research Ethics. Jul2026, Vol. 22 Issue 3, p507-527. 21p.

Effectiveness of pharmacogenomics-guided dosing in improving treatment outcomes.

Authors: Karthikeyan, L. V. Subamathi, A. Pragathi, P. et al.

Source: Indian Journal of Pharmacology. Jul/Aug2026, Vol. 58 Issue 4, p332-341. 10p.

Cost-effectiveness of pre-emptive pharmacogenetic testing: An umbrella review.

Authors: Ochi, Taichi den Uil, Manon G. Piazza, Greta et al.

Source: PLoS ONE. 6/16/2026, Vol. 21 Issue 6, p1-18. 18p.

Cardiologists' perspectives on pharmacogenomics implementation in a hybrid health system: A qualitative study from the United Arab Emirates.

Authors: Abbas, Maram O. Rahma, Azhar T. Elbarazi, Iffat et al.

Source: PLoS ONE. 6/21/2026, Vol. 21 Issue 6, p1-17. 17p.

Actionable medications in Australian Vietnam War veterans: Implications for pre-emptive pharmacogenetic testing.

Authors: Tan, Wei Liang Andre Mellor, Rebecca Bennett, Darcy et al.

Source: Australasian Psychiatry. Jun2026, Vol. 34 Issue 3, p275-283. 9p.

Subjects: Cytochrome P-450 CYP2C19, Polypharmacy, Drug interactions, Pharmacogenomics, Medication safety, Vietnam veterans, Drug metabolism, Predictive tests

Global Geo-Pharmacogenomics: Environmental Mutational Signatures Drive Population-Level Heterogeneity in Anticancer Drug Response.

Authors: Jawahar, Janiel James, Samuel

Source: Journal of Xenobiotics. Jun2026, Vol. 16 Issue 3, p87. 25p.

Pharmacogenomic Stratification for Oncology Drug Repurposing: An Exposure Target Context Eligibility Framework.

Authors: El-Tanani, Mohamed Wali, Adil Farooq Rabbani, Syed Arman et al.

Source: Pharmaceuticals (14248247). Jun2026, Vol. 19 Issue 6, p957. 27p.

Evaluating the Use of Tumor Bank DNA to Validate Genetic Factors Impacting Opioid Response in Patients with Advanced Cancer.

Authors: Watt, Christine L. Lelievre, Rebecca Parsons, Gaelle Chopin Stukart et al.

Source: Current Oncology. Jun2026, Vol. 33 Issue 6, p363. 12p.

Postoperative Pain in Patients Receiving Ketoprofen After Total Hip Arthroplasty: The Role of Pharmacogenetics.

Authors: Denisenko, Natalia P. Anderzhanova, Anastasia A. Lysov, Dmitriy A. et al.

Source: Future Pharmacology. Jun2026, Vol. 6 Issue 2, p28. 14p.

Monogenic Syndromes as a Cause of Adverse Drug Reactions in the Russian Population.

Authors: Buianova, Anastasiia A. Cheranev, Valery V. Shmitko, Anna O. et al.

Source: International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 11, p4851. 16p.

Pharmacogenomics knowledge and implementation readiness among community pharmacists in Jordan: A national cross-sectional study.

Authors: Al-Kubaisi, Khalid Awad Abdel-Qader, Derar H. Al Mazrouei, Nadia et al.

Source: PLoS ONE. 5/19/2026, Vol. 21 Issue 5, p1-18. 18p.

Integrating Pharmacogenomics and Network Topology for Machine Learning Prediction of HLA-Associated Severe Cutaneous Adverse Drug Reactions.

Authors: Ponduan, Tanaporn Kunsombut, Arisara Paklao, Thummarat et al.

Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 10, p4187. 24p.

A roadmap to tomorrow's clinic: integrating pharmaco-multiomics and AI for precision perinatal psychiatry.

Authors: Ismail, Mohamed A.¹ (AUTHOR) Mhmd_arby@yahoo.com

Source: AAPS Open. 5/11/2026, Vol. 12 Issue 1, p1-16. 16p.

From Genotype to Functional Risk: A Multi-Omic Approach to Predicting Thiopurine and Methotrexate Co-Therapy-Induced Liver Injury.

Authors: Molnár, Dénes Reznik, Elizabeth Porrogi, Pálma

Source: Pharmaceuticals (14248247). May2026, Vol. 19 Issue 5, p733. 25p.

The Role of the Pediatric Pharmacist in Precision Medicine and Clinical Pharmacogenomics for Children.

Authors: Cook, Kelsey J. Duong, Benjamin Q. Kim, Hyun et al.

Source: Journal of Pediatric Pharmacology & Therapeutics. 2026, Vol. 31 Issue 3, p437-443. 7p.

钠−葡萄糖协同转运蛋白 2 的基因组学研究进展及其抑制剂的临床应用.

Alternate Title: Advances in genomics of SGLT2 and clinical application of SGLT2 inhibitors.

Authors: 邓晓霞 田 泾 苏健芬

Source: Journal of Pharmaceutical Practice & Service. May2026, Vol. 44 Issue 5, p228-232. 5p.

Impact of Pharmacogenetic Markers on the Efficacy of Neoadjuvant FLOT Chemotherapy in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma.

Authors: Fedorinov, Denis Lyadov, Vladimir Lyadova, Marina et al.

Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 9, p4114. 10p.

Extrapyramidal and anticholinergic reactions in an adolescent patient: a case for pharmacogenetic consideration.

Authors: Išasegi, Iris Žunić Stefanović, Ivana Želalić, Marta Okružnik et al.

Source: Biochemia Medica. 2026, Vol. 36 Issue 2, p1-8. 8p.

The Emerging Crisis in Non-Prescribed Ketamine Use: A Rapid Attenuation of Depression in Face of Abuse and "Chill-out" or Escapism Drug.

Authors: Lewandrowski, Kai Uwe Blum, Kenneth Schmidt, Sergio et al.

Source: Substance Use & Misuse. 2026, Vol. 61 Issue 9, p1532-1549. 18p.

Subjects: Prevention of mental depression, Substance abuse, Ketamine, Epigenomics, Prefrontal cortex, Neuroplasticity, Treatment effectiveness, Brain diseases, Antidepressants, Suicide prevention, Pharmacogenomics, Serotonin, Mental depression, Drug resistance, Neurotransmitters, Psychiatric drugs, Nonprescription drugs, Pharmacodynamics

Geographic Terms: United States, United Kingdom, Europe